Zhang et al., 2022 - Google Patents
Identification of novel diagnostic biomarkers in prostate adenocarcinoma based on the stromal‐immune score and analysis of the WGCNA and ceRNA networkZhang et al., 2022
View PDF- Document ID
- 9417635214825344830
- Author
- Zhang T
- Wang Y
- Dong Y
- Liu L
- Han Y
- Wang H
- Wei Q
- Xia P
- Ma W
- Li L
- Publication year
- Publication venue
- Disease Markers
External Links
Snippet
Prostate cancer is still a significant global health burden in the coming decade. Novel biomarkers for detection and prognosis are needed to improve the survival of distant and advanced stage prostate cancer patients. The tumor microenvironment is an important …
- 238000004458 analytical method 0 title description 24
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tekpli et al. | An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment | |
Das et al. | Integration of online omics-data resources for cancer research | |
Yao et al. | Integrated analysis of co‐expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer | |
Bagnoli et al. | Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study | |
Zhang et al. | Discovery of multi-dimensional modules by integrative analysis of cancer genomic data | |
Long et al. | Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence | |
Wang et al. | Novel biomarkers associated with progression and prognosis of bladder cancer identified by co-expression analysis | |
Wei et al. | Integrative analysis of MicroRNA and gene interactions for revealing candidate signatures in prostate cancer | |
He et al. | Genome-wide profiles of methylation, microRNAs, and gene expression in chemoresistant breast cancer | |
Zhang et al. | Identification of novel diagnostic biomarkers in prostate adenocarcinoma based on the stromal‐immune score and analysis of the WGCNA and ceRNA network | |
Xia et al. | Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis | |
Ma et al. | Applications of RNA indexes for precision oncology in breast cancer | |
Zhang et al. | Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network | |
Ge et al. | Expression profiles and clinical significance of MicroRNAs in papillary renal cell carcinoma: a STROBE-compliant observational study | |
Gan et al. | Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data | |
Yan et al. | Development of a four-gene prognostic model for pancreatic cancer based on transcriptome dysregulation | |
Hua et al. | miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers | |
Tian et al. | Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis | |
Ning et al. | Construction of a lncRNA-mediated feed-forward loop network reveals global topological features and prognostic motifs in human cancers | |
Zhao et al. | Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer | |
Wang et al. | Construction and analysis of competing endogenous RNA networks for breast cancer based on TCGA dataset | |
Li et al. | Prognostic value of the tumor‐specific ceRNA network in epithelial ovarian cancer | |
Liao et al. | A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma | |
Qin et al. | The dysregulation of SOX family correlates with DNA methylation and immune microenvironment characteristics to predict prognosis in hepatocellular carcinoma | |
Sun et al. | Identification of ten core hub genes as potential biomarkers and treatment target for hepatoblastoma |